Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02273739
Title Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Additional content available in CKB BOOST